news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Meijing AI News,Huaan Securities released a research report on August 26, giving Pien Tze Huang (600436.SH, latest price: 203.85 yuan) a buy rating. The reasons for the rating mainly include: 1) revenue and profit both increased in the first half of the year, sales continued to grow, and brand influence expanded; 2) pharmaceutical manufacturing grew steadily, and a large health product matrix was gradually formed; 3) pharmaceutical distribution and cosmetics industries both grew, online channels had higher gross profit margins, and offline growth was steady; 4) technological innovation driven and key breakthroughs, brand strengthening and quality improvement in parallel; 5) upstream and downstream expansion of the industrial chain, exploring the second growth curve. Risk warning: company promotion is not as expected, raw material prices fluctuate, and the growth rate of daily chemical/cosmetics business is not as expected, etc.

AI comment: Pianzihuang has received attention from 4 brokerage research reports in the past month, with 3 purchases and 1 increase in holdings. The average target price is 242.83 yuan, which is 38.97 yuan higher than the latest price of 203.85 yuan, and the average target price has increased by 19.12%.

Every headline (nbdtoutiao)——

(Reporter Hu Ling)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. You will be responsible for your own risks if you act accordingly.

Daily Economic News